Novartis
Source-claim record: this page may be based on an automated extraction. The figure may describe a plan, an aggregate or overlapping coverage and has not necessarily been independently verified as a completed layoff.
Reported figure
60
Reported or extracted reason
after $1.4B acquisition of Flatiron biotech
🔮 Oracle Verdict
This layoff has not yet been scored by the Oracle.
Source provenance
https://www.crainsnewyork.com/health-care/cny-tourmaline-bio-layoffs-20260622/via Google Alerts RSS